Sign up to save your podcasts
Or
Share 23: Mycrodose Therapeutics - Advanced Delivery Systems for Ketamine, Psilocybin and other Psychedelics - Interview with Chad Conner & Patrick Eckstrom
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
23: Mycrodose Therapeutics - Advanced Delivery Systems for Ketamine, Psilocybin and other Psychedelics - Interview with Chad Conner & Patrick Eckstrom
Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds. In this episode of The Integration Conversation, Mycrodose's Chad Conner and Patrick Eckstrom join Brom to discuss how ADD systems can potentially improve the patient experience, increase the safety profile and lower the cost of psychedelic drugs.
💰 Invest in Brom's Psychedelic VC Fund:
https://www.empath.vc
📺 Watch on YouTube:
https://youtu.be/HmBsrUQYyOg
🐦 brom on twitter:
https://twitter.com/therealbrom
🎇 Clips and other stuff on Instagram:
https://instagram.com/theintegrationco
💌 Email:
View all episodes
By Brom Rector and Sam Tabone
5
66 ratings
Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds. In this episode of The Integration Conversation, Mycrodose's Chad Conner and Patrick Eckstrom join Brom to discuss how ADD systems can potentially improve the patient experience, increase the safety profile and lower the cost of psychedelic drugs.
💰 Invest in Brom's Psychedelic VC Fund:
https://www.empath.vc
📺 Watch on YouTube:
https://youtu.be/HmBsrUQYyOg
🐦 brom on twitter:
https://twitter.com/therealbrom
🎇 Clips and other stuff on Instagram:
https://instagram.com/theintegrationco
💌 Email: